Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function

BMC Nephrology

Table 2 Individual analysis of patients with an increased D4/D0 after Dapagliflozin administration

Patient #	Age	Gender	BMI	Diabetic Status	History of Peritonitis	D4/D0		D/P		Na Dip		Weight
Patient #	Age	Gender	BMI	Diabetic Status	History of Peritonitis	Before	After	Before	After	Before	After	Before	After
2	65	F	40.6	+	-	0.31	0.34	0.61	0.63	15	10	104.4	105
3	55	F	36.6	+	+	0.38	0.4	0.67	0.57	16	16	115	112
4	47	M	31.8	+	-	0.22	0.25	0.89	0.82	6	6	80	81.5
6	52	M	29.4	+	+	0.21	0.23	0.88	0.83	12	10	92.5	90
8	77	F	22.3	+	-	0.26	0.31	0.8	0.87	6	6	57	57
12	59	M	25.6	+	-	0.17	0.27	0.9	0.81	4	7	78	82
1	47	F	24.5	-	+	0.19	0.41	0.81	0.67	7	6	69.5	66
7	36	F	22.1	-	+	0.28	0.32	0.7	0.69	11	11	47.5	44
11	45	F	22.7	-	-	0.26	0.37	0.67	0.54	10	12	59	58
13	50	F	24.3	-	-	0.32	0.33	0.64	0.65	8	11	73	74.5
14	44	M	28.4	-	-	0.3	0.32	0.7	0.71	6	7	90	87
15	37	M	19.6	-	+	0.23	0.25	0.7	0.77	14	11	58	58
17	22	F	36.6	-	-	0.26	0.27	0.89	0.81	4	10	92	89

ISSN: 1471-2369